Funding will help further build out the Agrospheres platform, which manufactures, encapsulates and delivers biological pesticides.
New funds will go towards commercializing Catalera products and building out the product development pipeline.
SOLASTA Bio says its biopeptide products perform “as effective or better than standard insecticides.”
The R&D partnership aims to eventually develop a commercial product.
US-based Robigo engineers plant microbiota into ‘molecular vigilantes,’ according to co-founder Connor Sweeney.
RNA plays an essential role in the genetic machinery of all living things – so there are myriad potential uses of bio-targeted RNA beyond agriculture, too.
The Dutch-Danish startup thinks that toxicity and growing pathogen resistance to chemical aqua-pesticides means that now’s the time to shine for biological alternatives.
The publicly-traded company is responding to the increasing number of countries banning chemical inputs by innovating bio-based solutions.
Vestaron wants farmers to know that its peptide-based products are different from existing microbial products, offering more consistent efficacy with the same environmental benefits.
Biological pesticide firm Greenlight Biosciences has raised an $18 million Series D round led by led by farmland and agtech fund investor Fall Line Capital.
The extension in funding has given AgroSavfe a prime slot within Sofinnova’s newly-launched, €106 million Industrial Biotech Fund that closed last week.
Terramera, a Canadian startup that’s on a mission to change the fate of many biological ag products, has raised $10 million in venture capital.
“Now we’ve got a much more structured approach and good clarity on our verticals (gene editing, ag biologicals, tech platforms, decision science), we feel comfortable making investments early,” says Dr. Tom Greene.
Cultivated meat advances in S. Korea while the US sees more legal battles for plant-based meat labeling.
At Apeel, we look to nature to help the global food system extend quality, prevent waste, and ensure an abundant future for our planet. We
After closing a $40 million Series B, Micropep now looks to bring its crop protection products based on micropeptides to market.
Plus: The “regenerative” versus “organic” debate rages on.
If traditional pesticides are blunt instruments for killing pests, RNAi (RNA interference) is the polar opposite, says Dr. John Husnik, CEO at Vancouver-based Renaissance Bioscience. “It’s exceptionally precise.”
Plus: NoPalm Ingredients raises funds for its palm oil alternative and layoffs at Cargill.
The 2024 Salinas Biological Summit unpacked the many ways in which the ag biologicals industry is adapting to a changing environment.
